Dr. Ari Katerelos, MD

Dr. Katerelos practices at Fhp Health Center in Honolulu, Hawaii.

Dr. Katerelos' NPI, 1861607418, was assigned on May 14, 2007. Dr. Katerelos graduated from David Geffen School of Medicine at UCLA in 2005. Dr. Katerelos holds California license A99003.

Dr. Katerelos' primary practice is Fhp Health Center, at 459 Patterson Rd, Honolulu, HI 96819 in Honolulu County. The practice phone is (671) 646-6956.

Dr. Katerelos' primary practice is Fhp Health Center in Honolulu, Hawaii. The medical group on file is City of Hope. Dmand AI also links Dr. Katerelos to 2 more group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katerelos practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Katerelos' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Katerelos is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Katerelos' licenses on file in 3 states: California, Guam and Georgia.

Dmand AI lists breast cancer radiation, colorectal cancer radiation, lung cancer radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Katerelos treats.

CMS data shows 3,243 Medicare services from Dr. Katerelos across 14 procedure codes in 2024, for 250 Medicare patients. Medicare paid $1,215,649 for them.

CMS counts 250 Medicare patients who saw Dr. Katerelos in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have cancer, and 66% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katerelos' median patient age at 70, with 47% women.

In 2019, Dr. Katerelos wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $466 in total drug cost. In 2018, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Katerelos for performance year 2024, reported as part of a group. Dr. Katerelos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Katerelos in 2013. Dr. Katerelos' most frequent co-authors are David Alan Bush, MD, Gregory Cheek, MD and Jerry D. Slater, MD.

CMS Open Payments shows 25 general payments to Dr. Katerelos from 13 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 53% of the total. AstraZeneca Pharmaceuticals LP paid the most, $566.

Dr. Katerelos graduated from David Geffen School of Medicine at UCLA in 2005.

Dr. Katerelos is in network with 14 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.